Lesia Slobozheniuk

Lesia Slobozheniuk

Auto-generated profile, based on publicly available information

Lesia Slobozheniuk

Central Clinical Hospital in Warsaw Banacha 1a Street, 02-097 Warszawa, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MBMagdalena Bieniak
Magdalena Bieniak
MMMaria Mamczak
Maria Mamczak
LSLesia Slobozheniuk
Lesia Slobozheniuk
MMMartyna Michalik
Martyna Michalik
JOJulia Ołdak
Julia Ołdak
JPJulia Płóciennik
Julia Płóciennik
Autism spectrum disorder (ASD) has traditionally been studies mainly involving male populations, which has influenced both diagnostic criteria and clinical expectations. Because early diagnostic criteria were built almost entirely around how boys present, we now face a reality where autistic girls and women are routinely missed. They end up spending years—often well into adulthood—navigating this heavy, unexplained social friction and emotional burnout before anyone actually connects the dots. This review is an attempt to unpack that female autism phenotype, looking closely at camouflaging, why the system fails them, and what exactly keeps these diagnoses delayed for so long. To get a clearer picture, we went through literature from 2000 to 2025 across PubMed, Scopus, and similar databases, focusing on sex-based differences, coping mechanisms, and co-occurring mental health issues. What the data actually shows is that autistic women rarely fit the old textbook mold. Their social differences are much quieter, and their verbal skills often hide the struggles. To survive, they rely heavily on "camouflaging"—essentially a polite term for masking their traits and mimicking neurotypical peers just to blend in. Sure, it works to get them through the day, but the internal cost is massive. We are talking severe anxiety, clinical depression, and sheer exhaustion. Since standard diagnostic tools still hunt for overt male behaviors, this whole internal struggle remains largely invisible to clinicians.

26 August 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JOJulia Ołdak
Julia Ołdak
MBMagdalena Bieniak
Magdalena Bieniak
LSLesia Slobozheniuk
Lesia Slobozheniuk
OKOleksandra Korshak
Oleksandra Korshak
ASAleksandra Skrobisz
Aleksandra Skrobisz
JPJulia Półciennik
Julia Półciennik
Background: Cardiovascular diseases are a major cause of death worldwide, with myocardial infarction being one of the most critical and time-sensitive conditions requiring urgent medical intervention. Coronary angiography is the gold standard diagnostic procedure for the assessment of coronary artery diseases. However, the access to such procedures heavily relies on the efficiency of the healthcare system worldwide. Several studies report that the COVID-19 pandemic may have contributed to a reduction in the number of cardiology procedures performed and an increase in mortality due to myocardial infarction. Aim: To evaluate the impact of the COVID-19 pandemic on the utilization of coronary angiography among patients aged ≥65 years hospitalized for myocardial infarction in the Mazowieckie Voivodeship, Poland. Methods: A retrospective analysis based on aggregated administrative data obtained from the National Health Fund (NFZ) upon request comparing 3 periods: pre-pandemic (2017-2019), pandemic (2020-2021) and post-pandemic (2022-2023). Results: The analysis revealed a decrease in hospitalizations (11.6%) and coronary angiographies performed (12.3%), along with an increase in mortality due to myocardial infarction (8.7%) in the pandemic period. Conclusions: Due to restrictions and fear of contracting COVID-19, patients reported symptoms and visited medical facilities less often. Other potential causes include STEMI misdiagnosis and increased use of pharmacological reperfusion due to COVID-19. The consequences of the pandemic require more investigation.

27 October 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JPJulia Płóciennik
Julia Płóciennik
KPKlara Płóciennik
Klara Płóciennik
ASAleksandra Skrobisz
Aleksandra Skrobisz
LSLesia Slobozheniuk
Lesia Slobozheniuk
MBMagdalena Bieniak
Magdalena Bieniak
OKOleksandra Korshak
Oleksandra Korshak
Social media is embedded in young adults’ daily routines and frequently extends into the biological night. This narrative review examines how the amount, timing, content, and degree of control over social media use relate to sleep duration, sleep quality, insomnia symptoms, circadian timing, depression, anxiety, loneliness, and suicidality. PubMed/MEDLINE, Scopus, and PsycINFO were searched for English-language literature available through August 2026, with priority given to systematic reviews, meta-analyses, longitudinal studies, experiments, randomized interventions, and authoritative clinical guidance. Problematic, bedtime, nocturnal, and emotionally dysregulated use showed more consistent associations with disturbed sleep and adverse mental-health outcomes than total duration alone. The principal mechanisms were sleep displacement, cognitive and emotional arousal, social comparison, fear of missing out, notification-related interruption, and evening light exposure. Sleep appears to operate as both a mediator and a bidirectional amplifier: distress can promote compensatory scrolling, while delayed or fragmented sleep can impair affect regulation. Nevertheless, causal inference remains limited by cross-sectional designs, self-report bias, heterogeneous exposure definitions, residual confounding, and rapidly changing platforms. Clinically, assessment should focus on timing, control, content, function, and perceived benefits. Individualized reduction strategies may be useful, but they should complement rather than replace evidence-based treatment of insomnia or psychiatric disorders.

6 November 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
OAOlena Abramchuk
Olena Abramchuk
LKLiliia Koshlak
Liliia Koshlak
YMYaryna Manila
Yaryna Manila
LSLesia Slobozheniuk
Lesia Slobozheniuk
ASArtem Shchebetun
Artem Shchebetun
IZIngrida Zamoyska
Ingrida Zamoyska
Background. Image-centered social media have changed how patients observe, edit, compare, and evaluate their appearance [1, 2]. Beauty filters can erase acne, pores, pigment variation, erythema, scars, and lines while also altering facial proportions, creating a continuously available idealized version of the user’s own skin and face [3]. Dermatologists and aesthetic clinicians increasingly encounter procedure requests framed by filtered selfies, influencer content, and videoconferencing images [4, 15]. The popular expression “Snapchat dysmorphia” describes part of this phenomenon but is not a recognized diagnosis and should not be used interchangeably with body dysmorphic disorder (BDD) [1, 2, 37]. Aim. To synthesize evidence along the pathway from digital modification of skin and facial appearance to appearance anxiety and cosmetic procedure requests, and to develop an evidence-informed clinical screening framework for dermatology and aesthetic medicine. Methods. A structured narrative search of PubMed/Google Scholar was conducted through 4 October 2026 using combinations of terms related to social media, filters, selfies, photo editing, skin and facial appearance, appearance anxiety, BDD, cosmetic dermatology, cosmetic surgery, screening, and aesthetic procedures. Reference lists of relevant systematic reviews, meta-analyses, clinical reviews, and professional guidance were examined. Evidence was organized by its position in the proposed clinical pathway: digital exposure and self-editing, appearance comparison and anxiety, procedure consideration, dysmorphic symptoms, and consultation outcomes. Priority was given to systematic reviews and meta-analyses, experimental and longitudinal studies, validated screening research, and clinical guidance. Results. Systematic reviews and experiments indicate that exposure to idealized appearance content can worsen short-term body or facial satisfaction and increase appearance comparison. Active behaviors, including repeated selfie editing and filter use, show more consistent associations with cosmetic procedure acceptance than total social media time. The evidence supports a plausible but not fully established pathway from digital self-modification to self-discrepancy, appearance surveillance, anxiety, and procedure requests. Effect sizes vary, most studies involve young women, and evidence linking filter exposure to completed procedures or long-term psychiatric outcomes remains limited. BDD is substantially overrepresented in dermatology and cosmetic settings. The proposed framework combines assessment of the objective dermatologic finding, digital appearance behaviors, preoccupation and impairment, validated BDD screening, expectations, prior procedures, and mental health risk to guide treatment, extended assessment, deferral, or referral. Conclusions. Filtered skin and facial images should be treated as clinically relevant sources of comparison and procedure expectations rather than as diagnostic entities. The proposed framework translates heterogeneous evidence into a reproducible consultation process. A positive BDD screen does not establish a diagnosis, but probable BDD, an anatomically impossible target, marked functional impairment, acute psychological distress, or self-harm risk should lead to postponement of elective treatment and appropriate mental health assessment.

2 July 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
YMYaryna Manila
Yaryna Manila
IZIia Zhaharina
Iia Zhaharina
YDYuliia Dubova
Yuliia Dubova
AKAleksandra Kłuś
Aleksandra Kłuś
AKAneta Kasperska
Aneta Kasperska
VDValery Doroshkov
Valery Doroshkov
Chronic psychological stress negatively affects systems including the female reproductive axis. Ovarian reserve, reflecting oocyte quantity and quality, is a determinant of fertility and reproductive aging. In contemporary society, uncertainty, economic instability, poor work-life balance, and expanding social roles of women contribute to delayed childbearing and attention to age-related fertility decline. This review evaluates the impact and long-term consequences of chronic psychological stress on ovarian reserve and reproductive aging in women. A narrative review was performed using PubMed and Scopus. The search included publications from the past 20 years on chronic psychological stress, ovarian reserve, ovarian dysfunction, premature ovarian insufficiency, and reproductive aging. Guidelines, original studies, and reviews were analyzed. Studies suggest that women exposed to chronic stress often report increased perceived stress before reproductive dysfunction appears. Clinical and demographic data indicate that chronic stress, emotional trauma, and major life events may contribute to ovarian dysfunction and act as triggers of premature ovarian insufficiency. These factors are associated with reduced ovarian reserve markers and hormonal changes, including altered AMH, FSH, and cortisol. Overall, evidence supports a possible link between chronic psychological stress and accelerated reproductive aging, although findings remain heterogeneous due to differences in study design, stress assessment, populations, and outcomes. Chronic stress appears to be associated with impaired ovarian function, decreased ovarian reserve, and earlier reproductive aging. These findings underline the need to identify at-risk women and integrate stress management, support, and preventive counseling into reproductive health care. Further studies are needed to clarify mechanisms, define biomarkers, and guide clinical practice.

31 August 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JJJakub Jucha
Jakub Jucha
DZDominik Zając
Dominik Zając
DDDominika Darasz
Dominika Darasz
AŁArtur Łukawski
Artur Łukawski
LSLesia Slobozheniuk
Lesia Slobozheniuk
WZWojciech ZięBka
Wojciech ZięBka
SGLT2i (sodium-glucose cotransporter 2 inhibitors), also called flozins or gliflozins, are a group of hypoglycemic agents that have revolutionized the approach in treatment of T2DM (type 2 diabetes mellitus). Recent years have witnessed a rise in number of neurological conditions, which requires novel approaches to be examined to provide neuroprotection in these patients. Some studies suggest that presence of SGLT2 receptors in the central nervous system can provide possible neuroprotective properties in Alzheimer and Parkinson disease with the use of SGLT2i. We aimed in this review to summarize current evidence of SGLT2i impact on the central nervous system (CNS), as well to define their potential role in the comprehensive management of patients with neurologic disorders. Methods and materials: A qualitative synthesis of the data focusing on SGLT2 inhibitors, Alzheimer and Parkinson disease was performed. This literature review of SGLT2 inhibitors effect on neuroprotection in neurodegenerative disorders included recent publications, primarily from the past 10 years, and was conducted from November 2023 to May 2026 using the PubMed database. We performed a systematic search using specific keywords and medical subject headings (MeSH terms) related to SGLT2 inhibitors, Alzheimer and Parkinson disease. The primary search terms were: “SGLT2 inhibitors”, “sodium-glucose cotransporter 2 inhibitors”, “Alzheimer disease”, “Parkinson disease”, “neuroprotection”, “mild cognitive impairment”, and “flozins”. The criteria for inclusion of articles were as follows: published before May 2026, written in English, peer-reviewed original research articles. Exclusion criteria included publications not available in full text, articles in languages other than English. Editorials, commentaries, and conference abstracts without full data were also excluded. Titles and abstracts of the retrieved articles were screened to determine eligibility based on the inclusion and exclusion criteria.